Abstract
Fifty patients with inoperable head and neck carcinomas were treated with Cisplatin-5-fluorouracil induction chemotherapy. After 3 years follow-up, characteristics of patients have been studied, that is: age, sex, stage, primary site, histological type, histological grade and performance status. The analysis of chemotherapy treatment and results on primary tumor and lymphatic areas are presented. A total response rate of 83.3% with 22.9% of complete response rate have been observed. Local treatment after chemotherapy is studied. Radiotherapy increased response in 33.4% of cases. Response duration and survival is to have a complete response after systemic and local treatment. Literature is revised.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma / drug therapy*
-
Carcinoma / mortality
-
Carcinoma / pathology
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Combined Modality Therapy
-
Dexamethasone / administration & dosage
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Follow-Up Studies
-
Head and Neck Neoplasms / drug therapy*
-
Head and Neck Neoplasms / mortality
-
Head and Neck Neoplasms / pathology
-
Humans
-
Mannitol / administration & dosage
-
Metoclopramide / administration & dosage
-
Neoplasm Staging
-
Remission Induction
Substances
-
Mannitol
-
Dexamethasone
-
Metoclopramide
-
Cisplatin
-
Fluorouracil